Advanced glycation endproducts and their pathogenic roles in neurological disorders

Advanced glycation end products as biomarkers and gerontotoxins – A basis to explore methylglyoxal-lowering agents for Alzheimer’s disease?

(2010) Martina Krautwald et al.   EXPERIMENTAL GERONTOLOGY

Advanced Glycation End Products in Extracellular Matrix Proteins Contribute to the Failure of Sensory Nerve Regeneration in Diabetes

(2009) Beatriz Duran-Jimenez et al.   DIABETES

The sour side of neurodegenerative disorders: the effects of protein glycation

(2009) Hugo Vicente Miranda et al.   JOURNAL OF PATHOLOGY

Diabetes preceding Parkinson's disease onset. A case–control study

(2009) Marco D'Amelio et al.   PARKINSONISM & RELATED DISORDERS

Advanced glycoxidation products and impaired diabetic wound healing

(2009) Melpomeni Peppa et al.   WOUND REPAIR AND REGENERATION

Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis

(2008) J. Iłżecka   ACTA NEUROLOGICA SCANDINAVICA

The RAGE Pathway

(2008) Ivan K. Lukic et al.   Annals of the New York Academy of Sciences

Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress

(2008) Naila Rabbani et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Diabetes and the peripheral nerve

(2008) Irina G. Obrosova   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Pro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B Pathway

(2008) Norman Cameron et al.   CURRENT DRUG TARGETS

Role of Advanced Glycation End Products in Diabetic Neuropathy

(2008) Kazuhiro Sugimoto et al.   CURRENT PHARMACEUTICAL DESIGN

Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array

(2008) Katrin Berbaum et al.   CYTOKINE

High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study

(2008) N. Rabbani et al.   DIABETOLOGIA

Cognitive Dysfunction and Diabetes Mellitus

(2008) Christopher T. Kodl et al.   ENDOCRINE REVIEWS

Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis

(2008) Åsa Andersson et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation

(2008) Katrin Bigl et al.   JOURNAL OF NEURAL TRANSMISSION

Soluble receptor for advanced glycation end products in multiple sclerosis: A potential marker of disease severity

(2008) Z Sternberg et al.   Multiple Sclerosis Journal

Advanced Glycation: Implications in Tissue Damage and Disease

(2008) Anna Gasser et al.   PROTEIN AND PEPTIDE LETTERS